Broadfin Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,113,986
Closed -$3.75M 75
2015
Q4
$3.75M Hold
1,113,986
0.23% 68
2015
Q3
$5.94M Sell
1,113,986
-186,014
-14% -$992K 0.33% 57
2015
Q2
$8.41M Buy
1,300,000
+1,229,572
+1,746% +$7.96M 0.45% 48
2015
Q1
$344K Buy
+70,428
New +$344K 0.03% 78